# A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)

> **NCT00447603** · PHASE3 · TERMINATED · sponsor: **Organon and Co** · enrollment: 40 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** hydrochlorothiazide (+) losartan potassium
- **DRUG:** losartan potassium
- **DRUG:** Placebo for Losartan
- **DRUG:** Placebo for Losartan/HCTZ

## Key facts

- **NCT ID:** NCT00447603
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05-24
- **Primary completion:** 2007-10-22
- **Final completion:** 2007-10-22
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Achieving site readiness and enrolling the trial within a reasonable time
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447603, "A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00447603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*